191 related articles for article (PubMed ID: 21844185)
61. The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.
Read ML; Seed RI; Modasia B; Kwan PP; Sharma N; Smith VE; Watkins RJ; Bansal S; Gagliano T; Stratford AL; Ismail T; Wakelam MJ; Kim DS; Ward ST; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
Mol Carcinog; 2016 Jan; 55(1):15-26. PubMed ID: 25408419
[TBL] [Abstract][Full Text] [Related]
62. Alterations of NIS expression in functioning thyroid nodules.
Gözü HI; Yavuzer D; Kaya H; Vural S; Sargın H; Gezen C; Sargın M; Akalın S
Kulak Burun Bogaz Ihtis Derg; 2010; 20(6):285-92. PubMed ID: 20961282
[TBL] [Abstract][Full Text] [Related]
63. Dietary flavonoids and iodine metabolism.
Schröder-van der Elst JP; Smit JW; Romijn HA; van der Heide D
Biofactors; 2003; 19(3-4):171-6. PubMed ID: 14757968
[TBL] [Abstract][Full Text] [Related]
64. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
65. Iodinated TG in Thyroid Follicles Regulate TSH/TSHR Signaling for NIS Expression.
Huang H; Shi Y; Liang B; Cai H; Cai Q
Biol Trace Elem Res; 2017 Dec; 180(2):206-213. PubMed ID: 28396984
[TBL] [Abstract][Full Text] [Related]
66. Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.
Watkins RJ; Imruetaicharoenchoke W; Read ML; Sharma N; Poole VL; Gentilin E; Bansal S; Bosseboeuf E; Fletcher R; Nieto HR; Mallick U; Hackshaw A; Mehanna H; Boelaert K; Smith VE; McCabe CJ
J Clin Endocrinol Metab; 2016 Dec; 101(12):4551-4563. PubMed ID: 27603901
[TBL] [Abstract][Full Text] [Related]
67. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
[TBL] [Abstract][Full Text] [Related]
68. Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency.
Espadinha C; Santos JR; Sobrinho LG; Bugalho MJ
Clin Endocrinol (Oxf); 2009 Apr; 70(4):629-35. PubMed ID: 18710471
[TBL] [Abstract][Full Text] [Related]
69. Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter.
Lin X; Fischer AH; Ryu KY; Cho JY; Sferra TJ; Kloos RT; Mazzaferri EL; Jhiang SM
J Clin Endocrinol Metab; 2004 May; 89(5):2344-50. PubMed ID: 15126562
[TBL] [Abstract][Full Text] [Related]
70. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells.
Ma R; Latif R; Davies TF
Thyroid; 2013 Apr; 23(4):385-91. PubMed ID: 23360087
[TBL] [Abstract][Full Text] [Related]
71. GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.
Kang HS; Kumar D; Liao G; Lichti-Kaiser K; Gerrish K; Liao XH; Refetoff S; Jothi R; Jetten AM
J Clin Invest; 2017 Dec; 127(12):4326-4337. PubMed ID: 29083325
[TBL] [Abstract][Full Text] [Related]
72. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
[TBL] [Abstract][Full Text] [Related]
73. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
74. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
[TBL] [Abstract][Full Text] [Related]
75. Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing.
Kleiman DA; Buitrago D; Crowley MJ; Beninato T; Veach AJ; Zanzonico PB; Jin M; Fahey TJ; Zarnegar R
J Surg Res; 2013 Jun; 182(1):85-93. PubMed ID: 22998776
[TBL] [Abstract][Full Text] [Related]
76. Single-Photon Emission Computed Tomography for Preclinical Assessment of Thyroid Radioiodide Uptake Following Various Combinations of Preparative Measures.
Zwarthoed C; Chatti K; Guglielmi J; Hichri M; Compin C; Darcourt J; Vassaux G; Benisvy D; Pourcher T; Cambien B
Thyroid; 2016 Nov; 26(11):1614-1622. PubMed ID: 27349131
[TBL] [Abstract][Full Text] [Related]
77. Iodide handling disorders (NIS, TPO, TG, IYD).
Targovnik HM; Citterio CE; Rivolta CM
Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):195-212. PubMed ID: 28648508
[TBL] [Abstract][Full Text] [Related]
78. Endogenous thyrocyte-produced nitric oxide inhibits iodide uptake and thyroid-specific gene expression in FRTL-5 thyroid cells.
Fozzatti L; Vélez ML; Lucero AM; Nicola JP; Mascanfroni ID; Macció DR; Pellizas CG; Roth GA; Masini-Repiso AM
J Endocrinol; 2007 Mar; 192(3):627-37. PubMed ID: 17332530
[TBL] [Abstract][Full Text] [Related]
79. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
[TBL] [Abstract][Full Text] [Related]
80. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
Chai W; Ye F; Zeng L; Li Y; Yang L
J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]